Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for BioRestorative Therapies (BRTX) over the last 15 years, with Q3 2025 value amounting to -$0.33.

  • BioRestorative Therapies' EPS (Basic) fell 15384.62% to -$0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.47, marking a year-over-year decrease of 279.72%. This contributed to the annual value of -$1.49 for FY2024, which is 5875.22% up from last year.
  • Latest data reveals that BioRestorative Therapies reported EPS (Basic) of -$0.33 as of Q3 2025, which was down 15384.62% from -$0.38 recorded in Q2 2025.
  • In the past 5 years, BioRestorative Therapies' EPS (Basic) ranged from a high of $1.04 in Q3 2023 and a low of -$5.1 during Q2 2021
  • Moreover, its 5-year median value for EPS (Basic) was -$0.76 (2023), whereas its average is -$1.28.
  • Its EPS (Basic) has fluctuated over the past 5 years, first plummeted by 173633653.31% in 2021, then surged by 18166.15% in 2023.
  • Quarter analysis of 5 years shows BioRestorative Therapies' EPS (Basic) stood at -$3.38 in 2021, then surged by 61.66% to -$1.29 in 2022, then surged by 41.0% to -$0.76 in 2023, then skyrocketed by 54.62% to -$0.35 in 2024, then grew by 4.76% to -$0.33 in 2025.
  • Its EPS (Basic) stands at -$0.33 for Q3 2025, versus -$0.38 for Q2 2025 and -$0.64 for Q1 2025.